Ozanimod for the treatment of relapsing remitting multiple sclerosis. Rasche, L. and Paul, F. Expert Opinion on Pharmacotherapy 19 (18): 2073-2086. December 2018
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
